Literature DB >> 17200703

The role of gut hormones in glucose homeostasis.

Daniel J Drucker1.   

Abstract

The gastrointestinal tract has a crucial role in the control of energy homeostasis through its role in the digestion, absorption, and assimilation of ingested nutrients. Furthermore, signals from the gastrointestinal tract are important regulators of gut motility and satiety, both of which have implications for the long-term control of body weight. Among the specialized cell types in the gastrointestinal mucosa, enteroendocrine cells have important roles in regulating energy intake and glucose homeostasis through their actions on peripheral target organs, including the endocrine pancreas. This article reviews the biological actions of gut hormones regulating glucose homeostasis, with an emphasis on mechanisms of action and the emerging therapeutic roles of gut hormones for the treatment of type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200703      PMCID: PMC1716213          DOI: 10.1172/JCI30076

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  125 in total

1.  Glucagon-like peptide 1 receptor signaling influences topography of islet cells in mice.

Authors:  Z Ling; D Wu; Y Zambre; D Flamez; D J Drucker; D G Pipeleers; F C Schuit
Journal:  Virchows Arch       Date:  2001-04       Impact factor: 4.064

2.  Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.

Authors:  P B Jeppesen; B Hartmann; J Thulesen; J Graff; J Lohmann; B S Hansen; F Tofteng; S S Poulsen; J L Madsen; J J Holst; P B Mortensen
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

3.  Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

Authors:  T Vilsbøll; T Krarup; C F Deacon; S Madsbad; J J Holst
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

4.  Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats.

Authors:  R Perfetti; J Zhou; M E Doyle; J M Egan
Journal:  Endocrinology       Date:  2000-12       Impact factor: 4.736

5.  Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice.

Authors:  B Ahrén; J J Holst; H Mårtensson; B Balkan
Journal:  Eur J Pharmacol       Date:  2000-09-15       Impact factor: 4.432

6.  Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor.

Authors:  R P Boushey; B Yusta; D J Drucker
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

7.  Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling.

Authors:  A Trümper; K Trümper; H Trusheim; R Arnold; B Göke; D Hörsch
Journal:  Mol Endocrinol       Date:  2001-09

8.  Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide.

Authors:  C F Deacon; M A Nauck; J Meier; K Hücking; J J Holst
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

9.  Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice.

Authors:  L Baggio; T J Kieffer; D J Drucker
Journal:  Endocrinology       Date:  2000-10       Impact factor: 4.736

10.  Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats.

Authors:  F C Lynn; N Pamir; E H Ng; C H McIntosh; T J Kieffer; R A Pederson
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

View more
  208 in total

1.  Pharmacokinetic study of saxagliptin in healthy Chinese subjects.

Authors:  Haiyan Li; Li Yang; Conrad K P Tou; Chirag G Patel; June Zhao
Journal:  Clin Drug Investig       Date:  2012-07-01       Impact factor: 2.859

2.  Glucose sensing by gut endocrine cells and activation of the vagal afferent pathway is impaired in a rodent model of type 2 diabetes mellitus.

Authors:  Jennifer Lee; Bethany P Cummings; Elizabeth Martin; James W Sharp; James L Graham; Kimber L Stanhope; Peter J Havel; Helen E Raybould
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-07       Impact factor: 3.619

Review 3.  Type 2 diabetes mellitus: a possible surgically reversible intestinal dysfunction.

Authors:  Priscila C Sala; Raquel S Torrinhas; Steven B Heymsfield; Dan L Waitzberg
Journal:  Obes Surg       Date:  2012-01       Impact factor: 4.129

Review 4.  Homeostatic regulation of protein intake: in search of a mechanism.

Authors:  Christopher D Morrison; Scott D Reed; Tara M Henagan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-02-08       Impact factor: 3.619

Review 5.  Diet: friend or foe of enteroendocrine cells--how it interacts with enteroendocrine cells.

Authors:  Sofia Moran-Ramos; Armando R Tovar; Nimbe Torres
Journal:  Adv Nutr       Date:  2012-01-05       Impact factor: 8.701

Review 6.  Incretins and selective renal sodium-glucose co-transporter 2 inhibitors in hypertension and coronary heart disease.

Authors:  Ramiro A Sanchez; Hugo Sanabria; Cecilia de Los Santos; Agustin J Ramirez
Journal:  World J Diabetes       Date:  2015-09-10

7.  A Single-Cell Transcriptomic Map of the Human and Mouse Pancreas Reveals Inter- and Intra-cell Population Structure.

Authors:  Maayan Baron; Adrian Veres; Samuel L Wolock; Aubrey L Faust; Renaud Gaujoux; Amedeo Vetere; Jennifer Hyoje Ryu; Bridget K Wagner; Shai S Shen-Orr; Allon M Klein; Douglas A Melton; Itai Yanai
Journal:  Cell Syst       Date:  2016-09-22       Impact factor: 10.304

8.  GLP-1R activation for the treatment of stroke: updating and future perspectives.

Authors:  Vladimer Darsalia; David Nathanson; Thomas Nyström; Thomas Klein; Åke Sjöholm; Cesare Patrone
Journal:  Rev Endocr Metab Disord       Date:  2014-09       Impact factor: 6.514

9.  The Impact of Preoperative BMI (Obesity Class I, II, and III) on the 12-Month Evolution of Patients Undergoing Laparoscopic Gastric Bypass.

Authors:  Eva M Ramírez; Omar Espinosa; Ricardo Berrones; Elisa M Sepúlveda; Lizbeth Guilbert; Miguel Solís; Carlos Zerrweck
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

10.  NFAT targets signaling molecules to gene promoters in pancreatic β-cells.

Authors:  Michael C Lawrence; Nofit Borenstein-Auerbach; Kathleen McGlynn; Faisal Kunnathodi; Rauf Shahbazov; Ilham Syed; Mazhar Kanak; Morihito Takita; Marlon F Levy; Bashoo Naziruddin
Journal:  Mol Endocrinol       Date:  2014-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.